New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis

Expert Review of Molecular Diagnostics

Volumn 6, Issue 3, 2006, Pages 413-422

  Pai, Madhukar ^a,b   Kalantri, Shriprakash ^c   Dheda, Keertan ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Interferon assay; Latent tuberculosis infection; T cell based assay; Tuberculin skin test; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; PROTEIN DERIVATIVE; TUBERCULIN; BACTERIAL ANTIGEN; TUBERCULOSTATIC AGENT;

CORRELATION ANALYSIS; GOLD STANDARD; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRE; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN INDURATION; T LYMPHOCYTE; TASK PERFORMANCE; TUBERCULIN TEST; TUBERCULOSIS; BLOOD; DIAGNOSTIC PROCEDURE; ENZYME IMMUNOASSAY; IMMUNOLOGICAL PROCEDURES; MASS SCREENING; METHODOLOGY;

ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC TESTS; INTERFERON TYPE II; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33745961136     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.3.413     Document Type: Review

References (58)

1. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163(9), 1009-1021 (2003).
2. WHO. Global tuberculosis control. Surveillance, planning, financing. WHO Report 2005. WHO, Geneva, Switzerland 1-247 (2005).
3. Foulds J, O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int. J. Tuberc. Lung Dis. 2(10), 778-783 (1998).
4. Perkins MD. New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis. 4(12 Suppl. 2), S182-S188 (2000).
5. Perkins MD, Small PM. Admitting defeat. Int. J. Tuberc. Lung Dis. 10(1), 1 (2006).
6. Stop TB Partnership, WHO. The Global Plan to Stop TB 2006 - 2015. WHO, Geneva, Switzerland (2006). • Important recent document that outlines the global plan to control tuberculosis and the investments that need to be made, including the development of new tools.
7. Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin. Chest Med. 26(2), 247-271, vi (2005).
8. Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur. Respir. J. 26(2), 339-350 (2005).
9. Hazbon MH. Recent advances in molecular methods for early diagnosis of tuberculosis and drug-resistant tuberculosis. Biomedica 24(Supp 1), 149-162 (2004).
10. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc. Am. Thorac. Soc. 3, 103-110 (2006).
11. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161(4 Pt 2), S221-S247 (2000).
12. Menzies RI. Tuberculin skin testing. In: Tuberculosis: a Comprehensive International Approach. Reichman LB, Hershfield ES (Eds), Marcel Dekker, NY, USA, 279-322 (2000).
13. Menzies D. What does tuberculin reactivity after bacille Calmette-Guerin vaccination tell us? Clin. Infect. Dis. 31(Suppl. 3), S71-S74 (2000).
14. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4(12), 761-776 (2004). • Comprehensive review of both commercial and in-house interferon-γ release assays.
15. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-γ assay for the management of tuberculosis. Curr. Opin. Pulm. Med. 11(3), 195-202 (2005). • Clinically oriented review of commercial interferon-γ assays.
16. Pai M. Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection. Indian J. Med. Microbiol. 23(3), 151-158 (2005).
17. Lalvani A. Spotting latent infection: path to better tuberculosis control. Thorax 58(11), 916-918 (2003).
18. Rothel JS, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev. Anti Infect. Ther. 3(6), 981-993 (2005).
19. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 356(9235), 1099-1104 (2000).
20. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178(5), 1274-1282 (1996).
21. Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON-TB GOLD test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54(RR-15), 49-55 (2005). • Most recent US Centers for Disease Control and Prevention guidelines on the QuantiFERON®-TB GOLD test.
22. Whalen CC. Diagnosis of latent tuberculosis infection: measure for measure. JAMA 293(22), 2785-2787 (2005).
23. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170(1), 59-64 (2004).
24. Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 12(4), 491-496 (2005).
25. Kang YA, Lee HW, Yoon HI et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293(22), 2756-2761 (2005).
26. Pai M, Joshi R, Dogra S et al. Preliminary results from an evaluation of a whole-blood, interferon-γ assay in individuals with tuberculosis infection and disease in a rural Indian hospital. Int. J. Tuberc. Lung Dis. 9(11), S262 (2005).
27. Lalvani A, Pathan AA, McShane H et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 163(4), 824-828 (2001).
28. Lalvani A, Nagvenkar P, Udwadia Z et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis. 183(3), 469-477 (2001).
29. Pathan AA, Wilkinson KA, Klenerman P et al. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167(9), 5217-5225 (2001).
30. Chapman AL, Munkanta M, Wilkinson KA et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16(17), 2285-2293 (2002).
31. Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364(9452), 2196-2203 (2004).
32. Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 24(8), 529-536 (2005).
33. Goletti D, Vincenti D, Carrara S et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a γ interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin. Diagn. Lab. Immunol. 12(11), 1311-1316 (2005).
34. US Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 54(No.RR-17), 1-141 (2005).
35. Pai M, Joshi R, Dogra S et al. QuantiFERON-TB GOLD assay for serial testing in health care workers: boosting, conversions, and reversions. 10th Annual Meeting of the International Union Against Tuberculosis and Lung Disease (North American Region), IL, USA (2006)
36. Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361(9364), 1168-1173 (2003).
37. Lalvani A, Pathan AA, Durkan H et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357(9273), 2017-2021 (2001).
38. Pai M, Gokhale K, Joshi R et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-γ assay with tuberculin skin testing. JAMA 293, 2746-2755 (2005).
39. Mahomed H, Hughes EJ, Hawkridge T et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Int. J. Tuberc. Lung Dis. 10(3), 310-316 (2006).
40. Hill PC, Brookes RH, Fox A et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin. Infect. Dis. 38(7), 966-973 (2004).
41. Richeldi L, Ewer K, Losi M et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med. 170(3), 288-295 (2004).
42. Shams H, Weis SE, Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 172(9), 1161-1168 (2005).
43. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med. 170(1), 65-69 (2004).
44. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int. J. Tuberc. Lung Dis. 9(11), 1242-1247 (2005).
45. Dogra S, Narang P, Mendiratta DK et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J. Infect. (2006) (In Press).
46. Ferrara G, Losi M, Meacci M et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 172(5), 631-635 (2005).
47. Pai M, Lewinsohn DM. Interferon-γ assays for tuberculosis: is anergy the Achilles' heel? Am. J. Respir. Crit. Care Med. 172(5), 519-521 (2005).
48. Dheda K, Lalvani A, Miller RF et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19(17), 2038-2041 (2005).
49. Doherty TM, Demissie A, Olobo J et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol. 40(2), 704-706 (2002).
50. Stop TB Working Group on New Diagnostics www.stoptb.org/wg/ new_diagnostics
51. Foundation for Innovative New Diagnostics www.finddiagnostics.org
52. Tuberculosis Diagnostics Initiative, Special Programme for Research and Training in Tropical Diseases, WHO www.who.int/tdr/diseases/tb/tbdi.htm
53. Aeras Global Tuberculosis Vaccine Foundation http://aeras.org
54. Global Alliance for Tuberculosis Drug Development www.tballiance.org
55. Oxford Immunotec Ltd www.oxfordimmunotec.com
56. Cellestis, Ltd www.cellestis.com
57. US Centers for Disease Control and Prevention guidelines on QuantiFERON®-TB GOLD www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a4.htm
58. National Institute for Health and Clinical Excellence. Clinical Guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE, London, UK, (2006). www.nice.org.uk/page.aspx?o=CG033NICE guideline • UK National Institute for Health and Clinical Excellence guidelines on tuberculosis.